Entia Biosciences competitorsClear all

Entia Biosciences's top competitors include Touchlight Genetics, Personal Genome Diagnostics (PGD), Eloxx Pharmaceuticals and Osiris Therapeutics.

Save Comparison	Entia Biosciences Entia Biosciences offers nutrigenomics identifying and validating solutions for the organic health, beauty, and agricultural markets.	Touchlight Genetics Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology.	Personal Genome Diagnostics (PGD) Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies.	Eloxx Pharmaceuticals Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases.	Osiris Therapeutics Osiris Therapeutics researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States.
Founding Date	Founding Date N/A	Founding Date 2008	Founding Date 2010	Founding Date 2013	Founding Date 1992
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare agritech biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Sherwood, US HQ	Locations London, GB HQ	Locations Baltimore, US HQ	Locations Waltham, US HQ Rehovot, IL	Locations Columbia, US HQ
Employees	Employees 12	Employees 333% increase	Employees 230	Employees 2993% increase	Employees 3421% increase
Valuation ($)	Valuation ($) 279 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 351.2 m	Valuation ($) 655.7 m
Alexa Website Rank	Alexa Website Rank 311342	Alexa Website Rank 566835	Alexa Website Rank 632924	Alexa Website Rank N/A	Alexa Website Rank 527479
Financial
Revenue (est.)	Revenue (est.) $265.5k (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $142.8m (FY, 2018)
Cost of goods	Cost of goods $91.5k (FY, 2016)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $38.1m (FY, 2018)
Gross profit	Gross profit $174k (FY, 2016)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $104.7m (FY, 2018)
Net income	Net income ($1.4m) (FY, 2016)	Net income N/A	Net income N/A	Net income ($47.2m) (FY, 2018)	Net income $36.9m (FY, 2018)
Funding
Total funding raised	Total funding raised $ 1.5m	Total funding raised N/A	Total funding raised $ 141.3m	Total funding raised $ 30m	Total funding raised $ 65m